Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001055439 | SCV001219832 | uncertain significance | not provided | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid with valine at codon 256 of the PDE6C protein (p.Asp256Val). The aspartic acid residue is highly conserved and there is a large physicochemical difference between aspartic acid and valine. This variant is present in population databases (rs762557292, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with PDE6C-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Department of Pathology and Laboratory Medicine, |
RCV005394694 | SCV006058021 | uncertain significance | Cone dystrophy 4 | 2022-03-15 | criteria provided, single submitter | research |